XML 37 R15.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Investments | 12 Months Ended
--- | ---
Jun. 30, 2024
Equity Method Investments and Joint Ventures [Abstract] |
Investments | Investments Equity investments by measurement category as of June 30, 2024 and June 30, 2023 were as follows (in thousands):
Measurement category | 2024 |  | 2023
Fair value | $ | 12,026 |  |  | $ | 12,423 |
Measurement alternative | 73,739 |  |  | 68,748 |
Equity method | 65,462 |  |  | 65,366 |
Total | $ | 151,227 |  |  | $ | 146,537 |
The following table shows a reconciliation of the changes in our equity investments for the year ended June 30, 2024 (in thousands):
| Non-marketable securities |  | Marketable securities |  | Equity method investments |  | Total
Balance at the beginning of the period | $ | 68,748 |  |  | $ | 12,423 |  |  | $ | 65,366 |  |  | $ | 146,537 |
Additions to investments | 8,640 |  |  | 1,000 |  |  | 3,125 |  |  | 12,765 |
Observable price adjustments on non-marketable equity securities | 2,315 |  |  | — |  |  | — |  |  | 2,315 |
Impairment of investments | (4,963) |  |  | — |  |  | — |  |  | (4,963) |
Proceeds from exits of investments | (1,000) |  |  | — |  |  | — |  |  | (1,000) |
Unrealized losses on marketable equity securities | — |  |  | (1,397) |  |  | — |  |  | (1,397) |
Loss attributable to equity method investments | — |  |  | — |  |  | (1,848) |  |  | (1,848) |
Foreign currency translation adjustments | (1) |  |  | — |  |  | (1,181) |  |  | (1,182) |
Carrying value at the end of the period | $ | 73,739 |  |  | $ | 12,026 |  |  | $ | 65,462 |  |  | $ | 151,227 |
The following table shows a reconciliation of the changes in our equity investments for the year ended June 30, 2023 (in thousands):
| Non-marketable securities |  | Marketable securities |  | Equity method investments |  | Total
Balance at the beginning of the period | $ | 39,290 |  |  | $ | 9,167 |  |  | $ | 9,918 |  |  | $ | 58,375 |
Additions to investments (1) | 21,738 |  |  | 4,991 |  |  | 62,733 |  |  | 89,462 |
Observable price adjustments on non-marketable equity securities | 12,612 |  |  | — |  |  | — |  |  | 12,612 |
Impairment of investments | (4,892) |  |  | — |  |  | — |  |  | (4,892) |
Realized gains on marketable and non-marketable equity securities | 3,937 |  |  | — |  |  | — |  |  | 3,937 |
Proceeds from exits of investments | (3,937) |  |  | — |  |  | — |  |  | (3,937) |
Unrealized losses on marketable equity securities | — |  |  | (1,735) |  |  | — |  |  | (1,735) |
Loss attributable to equity method investments | — |  |  | — |  |  | (7,265) |  |  | (7,265) |
Dividends received | — |  |  | — |  |  | (2,873) |  |  | (2,873) |
Foreign currency translation adjustments | — |  |  | — |  |  | 2,853 |  |  | 2,853 |
Carrying value at the end of the period | $ | 68,748 |  |  | $ | 12,423 |  |  | $ | 65,366 |  |  | $ | 146,537 |
(1)Includes additions from purchases and an equity method investment acquired and measured at fair value via our acquisition of MEDIFOX DAN. Refer to Note 17 herein. Net unrealized gains and losses recognized in the years ended June 30, 2024, 2023 and 2022 for equity investments in non-marketable and marketable securities still held as of those respective dates were a loss of $4.0 million, a gain of $6.0 million, and a loss of $16.2 million, respectively.

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/320/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Topic 321 -Publisher FASB -URI https://asc.fasb.org/321/tableOfContent Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Topic 325 -Publisher FASB -URI https://asc.fasb.org/325/tableOfContent + Details
Name: | us-gaap_InvestmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration